Evaluation of the host immune response and functional recovery in peripheral nerve autografts and allografts.


Journal

Transplant immunology
ISSN: 1878-5492
Titre abrégé: Transpl Immunol
Pays: Netherlands
ID NLM: 9309923

Informations de publication

Date de publication:
04 2019
Historique:
received: 27 08 2018
revised: 24 01 2019
accepted: 25 01 2019
pubmed: 9 2 2019
medline: 25 6 2019
entrez: 9 2 2019
Statut: ppublish

Résumé

Allogeneic peripheral nerve (PN) transplants are an effective bridge for stimulating regeneration of segmental PN defects, but there are currently no detailed studies about the timeline and scope of the immunological response for PN allografting. In this study, the cellular immune response in PN allografts and autograft was studied during the acute and chronic phases of a 1.0 cm critical size defect in the rat sciatic nerve at 3, 7, 14, 28 and 98 days after grafting autologous or allogeneic nerves without any immunosuppressive treatment. The assessment was based on functional, histomorphometrical and immunohistochemical criteria. Results showed modestly better functional outcomes for autografts with coordinate and adaptive immune response represented by the presence of CD11c, CD3, CD4, NKp46 and CD8 cells at 3 days, CD45R positive cells and CD25 positive cells at seven and CD45R positive cells at 14 days which seems an adaptive immune response. In contrast, allograft in the early time points showed innate immune response instead of adaptive immune response until day 14, when there was some increase in cell-mediated immunity. In conclusion, in PN autografts the immune system is synchronic initiating with a more robust early innate response that more rapidly transitions to adaptive while for PN allografts the infiltration of immune cells is slower and more gradually progresses to a moderate adaptive response.

Identifiants

pubmed: 30735701
pii: S0966-3274(18)30123-0
doi: 10.1016/j.trim.2019.01.003
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-71

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103432
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Kelly Cristine Santos Roballo (KCS)

University of Wyoming, School of Pharmacy, Laramie, WY 82072, USA.

Jared Bushman (J)

University of Wyoming, School of Pharmacy, Laramie, WY 82072, USA. Electronic address: jbushman@uwyo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH